Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

NCT00651703 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

BIOLOGICAL: CYT004-MelQbG10 + Montanide
BIOLOGICAL: CYT004-MelQbG10 + Montanide + Imiquimod
BIOLOGICAL: CYT004-MelQbG10 + Imiquimod
BIOLOGICAL: CYT004-MelQbG10 intra nodal injection

Sponsor

Cytos Biotechnology AG